Bernstein SocGen Group Reiterates Outperform Rating on CVS Health (CVS), 'strong quarter'
Tweet Send to a Friend
Bernstein SocGen Group analyst Lance Wilkes reiterated an Outperform rating and $94.00 price target on CVS Health (NYSE: CVS).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
